KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMD) Finished Goods (2017 - 2025)

LifeMD (LFMD) has disclosed Finished Goods for 9 consecutive years, with $2.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Finished Goods rose 33.28% year-over-year to $2.1 million, compared with a TTM value of $2.1 million through Dec 2025, up 33.28%, and an annual FY2025 reading of $2.1 million, up 33.28% over the prior year.
  • Finished Goods was $2.1 million for Q4 2025 at LifeMD, down from $2.7 million in the prior quarter.
  • Across five years, Finished Goods topped out at $2.8 million in Q2 2022 and bottomed at $1.0 million in Q2 2024.
  • Average Finished Goods over 5 years is $1.9 million, with a median of $1.9 million recorded in 2023.
  • The sharpest move saw Finished Goods soared 259.97% in 2021, then crashed 57.06% in 2024.
  • Year by year, Finished Goods stood at $1.6 million in 2021, then surged by 62.46% to $2.6 million in 2022, then dropped by 26.61% to $1.9 million in 2023, then decreased by 18.13% to $1.6 million in 2024, then surged by 33.28% to $2.1 million in 2025.
  • Business Quant data shows Finished Goods for LFMD at $2.1 million in Q4 2025, $2.7 million in Q3 2025, and $2.5 million in Q2 2025.